Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hueber

Showing results (511-520 of 570) with videos related to

Pageof 57
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 16, 2014
Oncological and functional outcomes of 722 robot-assisted radical prostatectomy (RARP) cases: The largest Canadian 5-year experienceCôme Tholomier, Marc Bienz, Pierre-Alain Hueber, et al.
Arthritis Research & Therapy|February 28, 2021
Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugsAsmir Vodencarevic, Koray Tascilar, Fabian Hartmann, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2021
Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell DepletionDavid Simon, Koray Tascilar, Katja Schmidt, et al.
Urology|November 19, 2013
180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parametersPierre-Alain Hueber, Daniel Liberman, Tal Ben-Zvi, et al.
BJU International|March 13, 2016
Assessment of energy density usage during 180W lithium triborate laser photoselective vaporization of the prostate for benign prostatic hyperplasia. Is there an optimum amount of kilo-Joules per gram of prostate?Roger Valdivieso, Christian P Meyer, Pierre-Alain Hueber, et al.
Annals of the Rheumatic Diseases|January 31, 2013
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trialIain B McInnes, Joachim Sieper, Jürgen Braun, et al.
Lancet (London, England)|December 3, 2021
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trialSimon J Bowman, Robert Fox, Thomas Dörner, et al.
Plos One|April 25, 2013
The tyrosine phosphatase PTPN14 is a negative regulator of YAP activityChrysiis Michaloglou, Waltraut Lehmann, Typhaine Martin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2024
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging StudyThomas Dörner, Simon J Bowman, Robert Fox, et al.
Rheumatology International|October 10, 2022
Diagnostic delay stages and pre-diagnostic treatment in patients with suspected rheumatic diseases before special care consultation: results of a multicenter-based studyFranziska Fuchs, Harriet Morf, Jacob Mohn, et al.
Pageof 57

Showing results (511-520 of 570) with videos related to

Sort By:
Pageof 57
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 16, 2014
Oncological and functional outcomes of 722 robot-assisted radical prostatectomy (RARP) cases: The largest Canadian 5-year experienceCôme Tholomier, Marc Bienz, Pierre-Alain Hueber, et al.
Arthritis Research & Therapy|February 28, 2021
Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugsAsmir Vodencarevic, Koray Tascilar, Fabian Hartmann, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2021
Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell DepletionDavid Simon, Koray Tascilar, Katja Schmidt, et al.
Urology|November 19, 2013
180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parametersPierre-Alain Hueber, Daniel Liberman, Tal Ben-Zvi, et al.
BJU International|March 13, 2016
Assessment of energy density usage during 180W lithium triborate laser photoselective vaporization of the prostate for benign prostatic hyperplasia. Is there an optimum amount of kilo-Joules per gram of prostate?Roger Valdivieso, Christian P Meyer, Pierre-Alain Hueber, et al.
Annals of the Rheumatic Diseases|January 31, 2013
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trialIain B McInnes, Joachim Sieper, Jürgen Braun, et al.
Lancet (London, England)|December 3, 2021
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trialSimon J Bowman, Robert Fox, Thomas Dörner, et al.
Plos One|April 25, 2013
The tyrosine phosphatase PTPN14 is a negative regulator of YAP activityChrysiis Michaloglou, Waltraut Lehmann, Typhaine Martin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2024
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging StudyThomas Dörner, Simon J Bowman, Robert Fox, et al.
Rheumatology International|October 10, 2022
Diagnostic delay stages and pre-diagnostic treatment in patients with suspected rheumatic diseases before special care consultation: results of a multicenter-based studyFranziska Fuchs, Harriet Morf, Jacob Mohn, et al.
Pageof 57